Company/Organisation:
Janssen Pharmaceutica
Geographic Location
Country:
Belgium
Region:
Arr. Turnhout; Prov. Antwerpen; Vlaams Gewest
Location of affected unit(s):
Beerse
Company
Sector:
Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.2 - Manufacture of pharmaceutical preparations
Number Employed:
4750
Group:
Johnson & Johsnon
Employment Effects
Announcement Date:
25-01-2023
Planned Job Reductions min:
185
Planned Job Reductions max:
200
Type of Restructuring:
Internal restructuring
Employment Effect Start:
30-01-2023
Additional Information
Janssen Pharmaceutica, the Belgian branch of the multinational Johnson & Johnson group has announced it will dismiss between 185 and 200 employees within its Belgian division.The job cuts will take place in the research and developmen department.
According to the company management, the planned layoffs are partly caused by the current economic conditions. As the management expects these conditions to deteriorate further in the future, they want to take precautions and prevent significant issues from arising in the future. Trade unions are surprised by the decision of the company management as there were few indications that such a decision was at hand. It is also very rare within the company that this many people are dismissed at once.
MEMBER OF THE NETWORK OF EU AGENCIES
Eurofound is an agency of the European Union